Publicacions en què col·labora amb María Angeles Domínguez (23)

2022

  1. Genomic features of predominant non-PCV13 serotypes responsible for adult invasive pneumococcal disease in Spain

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 9, pp. 2389-2398

  2. Staphylococcus aureus surface protein G (sasG) allelic variants: correlation between biofilm formation and their prevalence in methicillin-resistant S. aureus (MRSA) clones

    Research in Microbiology, Vol. 173, Núm. 3

2020

  1. Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187

2019

  1. Monitoring the antimicrobial susceptibility of gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the smart study (Spain, 2016 and 2017)

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 145-155

  2. Rhodomyrtone decreases Staphylococcus aureus SigB activity during exponentially growing phase and inhibits haemolytic activity within membrane vesicles

    Microbial Pathogenesis, Vol. 128, pp. 112-118

2018

  1. Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among gram-negative organisms recovered during the SMART study in Spain (2011-2015)

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 2, pp. 136-145

  2. Diagnosis and treatment of catheter-related bloodstream infection: Clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC)

    Medicina Intensiva, Vol. 42, Núm. 1, pp. 5-36

  3. Executive summary: Diagnosis and Treatment of Catheter-Related Bloodstream Infection: Clinical Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, Núm. 2, pp. 112-119

2017

  1. High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2102-2109

2016

  1. Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderly

    Journal of Infection, Vol. 72, Núm. 3, pp. 309-316

2015

  1. Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 9, pp. 625.e1-625.e23

  2. Executive summary of the diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 9, pp. 626-632

  3. Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients

    BMC Infectious Diseases, Vol. 15, Núm. 1

2014

  1. Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin

    Journal of Antimicrobial Chemotherapy

  2. Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals

    Clinical Microbiology and Infection, Vol. 20, Núm. 4, pp. 361-367

2010

  1. Bacteriemias de presentación comunitaria y nosocomial por Staphylococcus aureus resistente a meticilina en hospitales españoles

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 6, pp. 336-341

2009

  1. Consensus document for the treatment of bacteremia and endicarditis caused by methicillin-resistent Staphylococcus aureus

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 27, Núm. 2, pp. 105-115

  2. Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus

    Journal of Infection, Vol. 58, Núm. 2, pp. 131-137

2007

  1. Recomendaciones para la selección de antimicrobianos en el estudio de la sensibilidad in vitro con sistemas automáticos y semiautomáticos

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 6, pp. 394-400

2006

  1. Control of methicillin-resistant Staphylococcus aureus in Spanish hospitals. A survey from the MRSA 2003 GEIH/GEMARA/REIPI project

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 24, Núm. 3, pp. 149-156